세계의 호흡 관리 디바이스 시장 예측(-2028년) : 제품, 질환, 적응증, 최종사용자별 예측, 주요 이해관계자, 기대, 미충족 요구, 구입 기준, 상환 환경

Respiratory Care Devices Market by Product (Therapeutic (CPAP, Ventilator, Nebulizer, Inhaler), Pulse Oximeter, Spirometer), Indication, End User, Key stakeholders & Expectations, Unmet needs, Buying Criteria, Reimbursement - Global Forecast to 2028

US $ 4,950 ￦ 7,096,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,534,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,684,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,337,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 호흡 관리 디바이스 시장 규모는 2023년 218억 달러에서 예측 기간 중 7.8%의 CAGR로 추이하며, 2028년에는 318억 달러 규모로 성장할 것으로 예측됩니다.

세계 노인 인구의 급격한 증가에 따른 호흡기질환의 유병률 증가가 시장 성장을 촉진할 것으로 보입니다.

조사 범위
조사 대상년도	2021-2028년
기준년도	2022년
예측 기간	2023-2028년
검토 단위	달러
부문	제품/질환/ 적응증/최종사용자
대상지역	북미, 유럽, 아시아태평양, 중남미, 중동 & 아프리카

제품별로는 인공호흡기 부문이 2022년 주요 점유율을 차지할 것으로 예상됩니다. 이 점유율은 인공호흡기를 갖춘 중환자실 병상 수 증가, 선진국의 중환자실 입실 및 재입실 증가, 유리한 상환 시나리오에 기인합니다.

질환별로는 만성폐쇄성폐질환(COPD) 부문이 주요 점유율을 차지하고 있습니다. 이 점유율은 흡연, 유전적 질환, 노인 인구 증가에 기인하며, COPD의 높은 유병률과 COPD로 인한 사망자 수 증가는 예측 기간 중 호흡 관리 디바이스에 대한 수요를 촉진할 것으로 예상됩니다.

지역별로는 아시아태평양이 예측 기간 중 가장 높은 CAGR로 성장할 것으로 예상됩니다. 이러한 성장은 주로 일본, 중국, 인도, 한국, 대만, 호주, 싱가포르와 같은 고성장 시장에 기인합니다. 이들 국가에서는 노인 인구 증가, 1인당 소득 증가, 주요 사업자의 의료 산업에 대한 투자 증가를 볼 수 있습니다.

세계의 호흡 관리 디바이스 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술·특허의 동향, 사례 연구, 법규제·상환 환경, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
  • 과제
• 업계의 동향
  • 고성능 컴팩트·휴대용 디바이스에 대한 수요의 증가
  • 시장 관계자의 주요 초점은 지역적 확대
  • 다양한 환기에 대한 수요의 증대
  • 비침습적 환기의 채택 증가
• 규제 분석
• 에코시스템 분석
• 밸류체인 분석
• COVID-19가 호흡 관리 디바이스 시장에 미치는 영향
• 기술 분석
• 특허 분석
• 무역 분석
• 사례 연구 분석
• Porter's Five Forces 분석
• 주요 컨퍼런스와 이벤트
• 주요 이해관계자와 구입 기준
• 가격 분석
• 미충족 요구
• 호흡기 관리 기기에서 AI의 응용
• 상환 시나리오

제6장 호흡 관리 디바이스 시장 : 제품별

• 치료
  • PAP 디바이스
  • 인공호흡기
  • 네뷸라이저
  • 가습기
  • 산소발생기
  • 흡입기
  • 재사용 가능 소생기
  • 일산화질소 공급 유닛
  • 산소 후드
• 모니터링
  • 펄스옥시미터
  • 카프노그래프
  • 가스 애널라이저
• 진단
  • 폐활량계
  • PSG 기기(POLYSOMNOGRAPHY DEVICES)
  • 피크 유량계
  • 기타
• 소모품·부속품
  • 마스크
  • 일회용 소생기
  • 기관절개 튜브
  • 호흡 회로
  • 비강 캐뉼라
  • 기타

제7장 호흡 관리 디바이스 시장 : 적응증별

• 만성폐쇄성폐질환(COPD)
• 수면무호흡
• 천식
• 감염증
• 기타

제8장 호흡 관리 디바이스 시장 : 최종사용자별

• 병원
• 홈케어
• 외래 치료 센터(ACCS)
• 기타

제9장 호흡 관리 디바이스 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 구도

• 유력 기업/주요 전략
• 주요 기업의 채택 전략
• TOP 5사의 매출 분석
• 시장 점유율 분석
• 기업 평가 매트릭스
• 중소기업·신규 기업 향 평가 매트릭스
• 경쟁 벤치마킹

제11장 기업 개요

• 주요 기업
  • KONINKLIJKE PHILIPS N.V.
  • MEDTRONIC
  • RESMED
  • MASIMO
  • FISHER & PAYKEL HEALTHCARE LIMITED
  • DRAGERWERK AG & CO. KGAA
  • GETINGE
  • NIHON KOHDEN CORPORATION
  • GE HEALTHCARE
  • VYAIRE MEDICAL, INC.
  • BAXTER INTERNATIONAL, INC.
  • ADAPTHEALTH, LLC
  • ROTECH HEALTHCARE, INC.
  • TELEFLEX INCORPORATED
  • AIR LIQUIDE
• 기타 기업
  • INVACARE CORPORATION
  • ICU MEDICAL
  • HAMILTON MEDICAL AG
  • APEX MEDICAL CORP
  • MEDLINE INDUSTRIES, LP
  • HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH
  • NONIN
  • ALLIED MEDICAL LLC
  • DRIVE DEVILBISS HEALTHCARE
  • OMRON HEALTHCARE, INC.

제12장 부록

KSA

영문 목차

영문목차

The global respiratory care devices market is projected to reach USD 31.8 billion by 2028 from USD 21.8 billion in 2023, at a CAGR of 7.8%. Rising prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population will drive the market growth.

Scope of the Report
Years Considered for the Study	2021-2028
Base Year	2022
Forecast Period	2023-2028
Units Considered	USD
Segments	Product Disease Indication End user
Regions covered	North America, Europe, APAC, LATAM, MEA

COPD and asthma are the most prevalent respiratory disorders across the globe. As per the WHO, COPD is the third leading cause of death worldwide, causing 3.2 million deaths in 2019. More than 80% of these deaths have occurred in low and middle-income countries. Over 380 million people globally are anticipated to have COPD. Largely undiagnosed COPD patients are high in regions and countries, such as China, India, Brazil, and Eastern Europe. The cost incurred to healthcare systems for COPD across the globe is nearly USD 50 billion annually. Some of the major causes of COPD are long-term asthma and prolonged exposure to tobacco smoke, indoor & outdoor air pollution, and occupational fumes & dust. Other comorbid chronic conditions, including cardiovascular disease, musculoskeletal impairment, and diabetes mellitus, are related to COPD. These conditions may also impact the health status of patients, as well as interfere with COPD management.

"The ventilators segment holds the major share of the therapeutic respiratory care devices market"

The therapeutic respiratory care devices market is segmented into ventilators, positive airway pressure (PAP) devices, humidifiers, nebulizers, oxygen concentrators, reusable resuscitators, inhalers, masks, nitric oxide delivery units, and oxygen hoods. In 2022, the ventilators segment holds the major share of the therapeutic respiratory care devices market. A large share of the ventilator segment can be attributed to the rising number of intensive care beds equipped with ventilators, increasing ICU admission and re-admissions in developed countries, and the favorable reimbursement scenario.

"The COPD segment holds the major share of the respiratory care devices market"

By disease indiation the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, infectious diseases, and other disease indications. The COPD segment holds the major share of the respiratory care devices market. A large share of the COPD segment can be attributed to the tobacco smoking, genetic disorders, and the increasing geriatric population. The high prevalence of COPD and the growing number of deaths caused by COPD are expected to drive the demand for respiratory care devices during the forecast period.

"The hospitals segment holds the major share of the respiratory care devices market"

By end user the respiratory care devices market is segmented into hospitals, home care settings, ambulatory care centers (ACCs), and other end users. The hospitals segment holds the major share of the respiratory care devices market. A large share of the hospitals segment can be attributed to the financial capabilities of hospitals to purchase expensive equipment and the availability of trained professionals in hospitals to operate respiratory care devices. Additionally, the trend of economic expansion and government focus on broader welfare policies has led to the growth of the healthcare sector in emerging economies.

"Asia Pacific will grow at highest CAGR during the forecast period"

In 2022, Asia Pacific will grow at highest CAGR during the forecast period. The high growth in this market can majorly be attributed to the to high-growth markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore. In these countries, the rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players.

"Improved profitability & mobility and enhanced remote moitoring-unmet needs in the respiratory care devices market"

• Many respiratory patients need oxygen therapy but require more lightweight, compact devices for increased mobility. Currently available portable devices may not fully meet this need.
• There's a growing demand for remote patient monitoring to reduce hospital admissions and improve patient outcomes. However, existing solutions may lack full integration or real-time data transmission.

The break-up of the profile of primary participants in the the respiratory care devices market (Supply Side):

• By Company Type: Tier 1 - 35%, Tier 2 - 40%, and Tier 3 - 25%
• By Designation: C Level - 20%, Director Level - 35%, Others-45%
• By Region: North America - 30%, Europe - 27%, Asia Pacific - 25%, Middle East - 10%, and Latin America - 8%

The break-up of the profile of primary participants in the the respiratory care devices market (Demand Side):

• By End User: Hospitals- 47%, Home Care- 33%, Others-20%
• By Designation: Doctors-35%, Diagnostic Centre Lab Heads-27%, Hospital Directors & Managers-22%, Others-16%
• By Region: North America-34%, Europe-22%, Asia Pacific-20%, Latin America-16%, Middle East & Africa-8%

The prominent players in the the respiratory care devices market include Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Masimo Corporation (US), Dragerwerk AG & Co.(Germany), Getinge AB (Sweden), Nihon Kohden Corporation (US), Vyaire Medical (US), Hill-Rom, Inc. (US), AdaptHealth LLC (US), Rotech Healthcare, Inc. (US), Teleflex Incorporated(Japan), Air Liquide (France), Invacare Corporation (US), ICU Medical Inc. (US), Hamilton Medical AG (Switzerland), Apex Medical Corporation (Taiwan), Apex Medical Corporation (US), HUM GmbH (Germany), Nonin Medical (US), Allied Healthcare Products, Inc. (US), Drive DeVilbiss Healthcare (US), OMRON Healthcare, Inc. (Japan).

Research Coverage:

The report analyzes the respiratory care devices market and aims at estimating the market size and future growth potential of this market based on various segments such as product, disease indication, end user and region. The report also includes a product portfolio matrix of various respiratory care devices available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall respiratory care devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (Rising Prevalence of Respiratory Diseases, Increasing incidence rate of preterm births, Outbreak of infectious diseases affecting the respiratory system, Underpenetrated markets in sleep and COPD, Focus on improving patient outcomes, Rising R&D investments resulting in technologically advanced devices), restraints (Unfavorable reimbursement scenario, Availability of low-cost products from local manufacturers, High cost of CPAP machines), opportunities (Growing demand for home care therapeutic devices, High growth in developing countries, Point-of-care Diagnostics, Growing awareness about the ill-effects of untreated sleep apnea), and challenges (Low awareness and a large underdiagnosed and undertreated population, Harmful effects of certain devices on neonates)
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the respiratory care devices market
• Market Development: Comprehensive information on the lucrative emerging markets by product, disease indication, end user and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global respiratory care devices market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), and Medtronic plc (Ireland) in the global respiratory care devices market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • FIGURE 1 RESPIRATORY CARE DEVICES MARKET SEGMENTATION
  • FIGURE 2 RESPIRATORY CARE DEVICES MARKET, BY REGION
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
  • TABLE 1 ANNUAL AVERAGE EXCHANGE RATE FOR CURRENCY CONVERSION, 2018-2022
• 1.5 STAKEHOLDERS
• 1.6 LIMITATIONS
• 1.7 SUMMARY OF CHANGES
• 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 3 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
  • FIGURE 4 PRIMARY SOURCES
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V.
  • FIGURE 10 SUPPLY-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2022)
  • FIGURE 11 DEMAND-SIDE MARKET ESTIMATION: VENTILATORS MARKET (2022)
  • FIGURE 12 TOTAL MARKET SIZE ESTIMATION: RESPIRATORY CARE DEVICES MARKET
  • FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2028)
  • FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 15 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 16 MARKET DATA TRIANGULATION METHODOLOGY
• 2.4 STUDY ASSUMPTIONS
  • 2.4.1 MARKET SHARE ASSUMPTIONS
  • 2.4.2 RESEARCH ASSUMPTIONS
• 2.5 RISK ASSESSMENT
  • TABLE 2 RESPIRATORY CARE DEVICES MARKET: RISK ASSESSMENT ANALYSIS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 17 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
• FIGURE 18 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 19 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
• FIGURE 20 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

• 4.1 RESPIRATORY CARE DEVICES MARKET OVERVIEW
  • FIGURE 21 HIGH TOBACCO CONSUMPTION TO BOOST MARKET GROWTH THROUGHOUT FORECAST PERIOD
• 4.2 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY TYPE (2022)
  • FIGURE 22 THERAPEUTIC RESPIRATORY CARE DEVICES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
• 4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 23 INDIA TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD
• 4.4 RESPIRATORY CARE DEVICES MARKET: REGIONAL MIX
  • FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET THROUGHOUT FORECAST PERIOD
• 4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES
  • FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER CAGRS DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 26 RESPIRATORY CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of respiratory diseases
      • 5.2.1.1.1 Rapid growth in global geriatric population
  • FIGURE 27 GLOBAL GERIATRIC POPULATION, BY REGION
    • 5.2.1.1.2 Urbanization and growing pollution levels
  • FIGURE 28 ANNUAL DATA OF DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE
    • 5.2.1.1.3 Growing tobacco consumption
  • TABLE 3 REGION-WISE DATA ON LIFESTYLE DISEASES
    • 5.2.1.1.4 Increased adoption of sedentary lifestyles
    • 5.2.1.2 Surging incidence rate of preterm births
  • TABLE 4 TOP 10 COUNTRIES WITH HIGHEST NUMBER OF PRETERM BIRTHS
  • TABLE 5 TOP 10 COUNTRIES WITH HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS
    • 5.2.1.3 Growing outbreaks of infectious diseases affecting respiratory systems
    • 5.2.1.4 Rising population with sleep disorders
    • 5.2.1.5 Improved patient outcomes using respiratory care devices
    • 5.2.1.6 Surging R&D investments for technological advancement of medical devices
  • TABLE 6 PRODUCT LAUNCHES
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Unfavorable reimbursement scenario for respiratory care diagnostics
    • 5.2.2.2 Availability of low-cost products from local manufacturers
    • 5.2.2.3 High cost of CPAP machines
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing demand for home care therapeutic devices
    • 5.2.3.2 Market growth opportunities in Asia Pacific and Latin America
    • 5.2.3.3 Increasing preference for self-testing
    • 5.2.3.4 Growing awareness about ill effects of untreated sleep apnea
  • TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT UNTREATED SLEEP APNEA
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Low awareness and lack of diagnosis of respiratory diseases
    • 5.2.4.2 Harmful effects of certain respiratory care devices on neonates
    • 5.2.4.3 Lack of patient compliance with CPAP therapy
• 5.3 INDUSTRY TRENDS
  • 5.3.1 RISING DEMAND FOR ENHANCED COMPACT AND PORTABLE DEVICES
  • 5.3.2 KEY FOCUS OF MARKET PLAYERS ON GEOGRAPHICAL EXPANSION
  • 5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATION
  • 5.3.4 RISING ADOPTION OF NON-INVASIVE VENTILATION
  • FIGURE 29 IMPACT OF INNOVATIVE SOLUTIONS
  • FIGURE 30 INTRODUCTION OF INNOVATIVE SOLUTIONS FOR SLEEP APNEA TREATMENT
• 5.4 REGULATORY ANALYSIS
  • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.4.2 NORTH AMERICA
    • 5.4.2.1 US
  • TABLE 11 US: CLASSIFICATION OF MEDICAL EQUIPMENT
  • TABLE 12 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.4.2.2 Canada
  • TABLE 13 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • 5.4.3 EUROPE
  • TABLE 14 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • 5.4.4 ASIA PACIFIC
    • 5.4.4.1 Japan
  • TABLE 15 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.4.4.2 China
  • TABLE 16 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.4.4.3 India
• 5.5 ECOSYSTEM ANALYSIS
  • FIGURE 31 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
  • FIGURE 32 RESPIRATORY CARE DEVICES MARKET: VALUE CHAIN ANALYSIS
• 5.7 IMPACT OF COVID-19 ON RESPIRATORY CARE DEVICES MARKET
• 5.8 TECHNOLOGY ANALYSIS
  • 5.8.1 E-NOSE TECHNOLOGY
  • 5.8.2 MEMS TECHNOLOGY
  • 5.8.3 ELECTROCHEMICAL TECHNOLOGY
  • 5.8.4 WIRELESS GAS SENSOR TECHNOLOGY
• 5.9 PATENT ANALYSIS
  • 5.9.1 PATENT PUBLICATION TRENDS FOR RESPIRATORY CARE DEVICES
  • FIGURE 33 PATENT PUBLICATION TRENDS (2015-2023)
  • 5.9.2 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY (2015-2023)
  • TABLE 17 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY
  • 5.9.3 RESPIRATORY CARE DEVICES MARKET: TOP APPLICANTS
  • FIGURE 34 TOP APPLICANTS FOR RESPIRATORY CARE DEVICES PATENTS (2015-2023)
• 5.10 TRADE ANALYSIS
  • TABLE 18 TOP EXPORTERS OF MEDICAL VENTILATORS, CPAP, BIPAP, AND OXYGEN CONCENTRATORS, 2021
• 5.11 CASE STUDY ANALYSIS
  • TABLE 19 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. EMERGING ECONOMIES
  • TABLE 20 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 21 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 THREAT OF NEW ENTRANTS
  • 5.12.2 THREAT OF SUBSTITUTES
  • 5.12.3 BARGAINING POWER OF SUPPLIERS
  • 5.12.4 BARGAINING POWER OF BUYERS
  • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.13 KEY CONFERENCES AND EVENTS, 2023-2024
  • 5.13.1 RESPIRATORY CARE DEVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • TABLE 22 STAKEHOLDERS IN BUYING PROCESS FOR RESPIRATORY CARE DEVICES
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES
  • 5.14.2 BUYING CRITERIA
  • FIGURE 35 KEY BUYING CRITERIA FOR RESPIRATORY DEVICES
  • TABLE 24 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES
• 5.15 PRICING ANALYSIS
  • TABLE 25 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES
• 5.16 UNMET NEEDS PERTAINING TO RESPIRATORY CARE DEVICES
  • TABLE 26 RESPIRATORY CARE DEVICES MARKET: UNMET NEEDS
  • 5.16.1 END USER EXPECTATIONS
  • TABLE 27 RESPIRATORY CARE DEVICES MARKET: END USER EXPECTATIONS
• 5.17 APPLICATION OF ARTIFICIAL INTELLIGENCE IN RESPIRATORY CARE DEVICES
  • TABLE 28 RESPIRATORY CARE DEVICES MARKET: APPLICATION OF ARTIFICIAL INTELLIGENCE
  • 5.17.1 FUTURE OF HEALTHCARE-BIG DATA AND ARTIFICIAL INTELLIGENCE
• 5.18 REIMBURSEMENT SCENARIO
  • TABLE 29 RESPIRATORY CARE DEVICES MARKET: REIMBURSEMENT SCENARIO

6 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 30 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 31 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.2 THERAPEUTIC RESPIRATORY CARE DEVICES
  • TABLE 32 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 33 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.1 PAP DEVICES
  • TABLE 34 PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 35 PAP DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 36 PAP DEVICES MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.1.1 CPAP devices
      • 6.2.1.1.1 Growing popularity of nasal CPAP therapies to drive demand
  • TABLE 37 MAJOR PLAYERS OFFERING CPAP DEVICES IN MARKET
  • TABLE 38 CPAP DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 39 CPAP DEVICES MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.1.2 APAP devices
      • 6.2.1.2.1 Rising awareness among sleep specialists and patients regarding additional features of APAP devices to boost market
  • TABLE 40 MAJOR PLAYERS OFFERING APAP DEVICES IN MARKET
  • TABLE 41 APAP DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 42 APAP DEVICES MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.1.3 BiPAP devices
      • 6.2.1.3.1 Increasing number of hospitals to strengthen market
  • TABLE 43 MAJOR PLAYERS OFFERING BIPAP DEVICES IN MARKET
  • TABLE 44 BIPAP DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 45 BIPAP DEVICES MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.2 VENTILATORS
  • TABLE 46 VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 47 VENTILATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 48 VENTILATORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.2.1 ICU ventilators
  • TABLE 49 MAJOR PLAYERS OFFERING ICU VENTILATORS IN MARKET
  • TABLE 50 ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 51 ICU VENTILATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 52 ICU VENTILATORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.2.1.1 High-end ventilators
      • 6.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive market
  • TABLE 53 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 54 HIGH-END VENTILATORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.2.1.2 Mid-end ventilators
      • 6.2.2.1.2.1 Better affordability and accessibility of mid-end ventilators than high-end models to support market growth
  • TABLE 55 MID-END VENTILATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 56 MID-END VENTILATORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.2.1.3 Basic ventilators
      • 6.2.2.1.3.1 Expanding access to critical healthcare facilities in developing countries to spur demand
  • TABLE 57 BASIC VENTILATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 58 BASIC VENTILATORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.2.2 Portable/Transportable ventilators
      • 6.2.2.2.1 Increasing demand for home care to boost segmental growth
  • TABLE 59 MAJOR PLAYERS OFFERING PORTABLE/TRANSPORTABLE VENTILATORS IN MARKET
  • TABLE 60 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 61 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.3 NEBULIZERS
  • TABLE 62 MAJOR PLAYERS OFFERING NEBULIZERS IN MARKET
  • TABLE 63 NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 64 NEBULIZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 65 NEBULIZERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.3.1 Jet nebulizers
      • 6.2.3.1.1 Increasing prevalence of respiratory conditions to augment market size
  • TABLE 66 JET NEBULIZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 67 JET NEBULIZERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.3.2 Mesh nebulizers
      • 6.2.3.2.1 Deployment of advanced aerosolization technology to drive market
  • TABLE 68 MESH NEBULIZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 69 MESH NEBULIZERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.3.3 Ultrasonic nebulizers
      • 6.2.3.3.1 Adjustable settings for particle size and treatment duration to boost market
  • TABLE 70 ULTRASONIC NEBULIZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 71 ULTRASONIC NEBULIZERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.4 HUMIDIFIERS
  • TABLE 72 HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 73 HUMIDIFIERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 74 HUMIDIFIERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.4.1 Heated humidifiers
      • 6.2.4.1.1 Ease of control and customizability to grow market
  • TABLE 75 MAJOR PLAYERS OFFERING HEATED HUMIDIFIERS IN MARKET
  • TABLE 76 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 77 HEATED HUMIDIFIERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.4.2 Passover humidifiers
      • 6.2.4.2.1 Minimal maintenance and simple technology to spur demand
  • TABLE 78 MAJOR PLAYERS OFFERING PASSOVER HUMIDIFIERS IN MARKET
  • TABLE 79 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 80 PASSOVER HUMIDIFIERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.5 OXYGEN CONCENTRATORS
  • TABLE 81 MAJOR PLAYERS OFFERING OXYGEN CONCENTRATORS IN MARKET
  • TABLE 82 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 83 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 84 OXYGEN CONCENTRATORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.5.1 Fixed oxygen concentrators
      • 6.2.5.1.1 Better access to healthcare services to grow demand
  • TABLE 85 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 86 FIXED OXYGEN CONCENTRATORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.5.2 Portable oxygen concentrators
      • 6.2.5.2.1 Low weight and easy setup to drive segmental growth
  • TABLE 87 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 88 PORTABLE OXYGEN CONCENTRATORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.6 INHALERS
  • TABLE 89 INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 90 INHALERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 91 INHALERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.6.1 Metered-dose inhalers (MDIs)
      • 6.2.6.1.1 Ongoing advancements in MDI technology to support market growth
  • TABLE 92 METERED-DOSE INHALERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 93 METERED-DOSE INHALERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.2.6.2 Dry powder inhalers (DPIs)
      • 6.2.6.2.1 Developments in particle engineering and powder formulations to boost segmental growth
  • TABLE 94 DRY POWDER INHALERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 95 DRY POWDER INHALERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.7 REUSABLE RESUSCITATORS
    • 6.2.7.1 Disposable and reusable nature to drive demand
  • TABLE 96 MAJOR PLAYERS OFFERING REUSABLE RESUSCITATORS IN MARKET
  • TABLE 97 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 98 REUSABLE RESUSCITATORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.8 NITRIC OXIDE DELIVERY UNITS
    • 6.2.8.1 Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market
  • TABLE 99 MAJOR PLAYERS OFFERING NITRIC OXIDE DELIVERY UNITS IN MARKET
  • TABLE 100 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 101 NITRIC OXIDE DELIVERY UNITS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.9 OXYGEN HOODS
    • 6.2.9.1 Growing prevalence of respiratory diseases in kids to drive market growth
  • TABLE 102 MAJOR PLAYERS OFFERING OXYGEN HOODS IN MARKET
  • TABLE 103 OXYGEN HOODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 104 OXYGEN HOODS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
• 6.3 MONITORING DEVICES
  • TABLE 105 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 106 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.1 PULSE OXIMETERS
  • TABLE 107 MAJOR PLAYERS OFFERING PULSE OXIMETERS IN MARKET
  • TABLE 108 PULSE OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 109 PULSE OXIMETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 110 PULSE OXIMETERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.3.1.1 Pulse oximeter sensors
      • 6.3.1.1.1 Development of advanced sensors with embedded chips to boost segmental growth
  • TABLE 111 PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 112 PULSE OXIMETER SENSORS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
    • 6.3.1.2 Pulse oximeter equipment
      • 6.3.1.2.1 Growing prevalence of chronic respiratory conditions to boost demand
  • TABLE 113 MAJOR PLAYERS OFFERING PULSE OXIMETER EQUIPMENT IN MARKET
  • TABLE 114 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 115 PULSE OXIMETER EQUIPMENT MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.3.2 CAPNOGRAPHS
    • 6.3.2.1 Ongoing R&D on capnographs to offer lucrative growth opportunities
  • TABLE 116 MAJOR PLAYERS OFFERING CAPNOGRAPHS IN MARKET
  • TABLE 117 CAPNOGRAPHS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 118 CAPNOGRAPHS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.3.3 GAS ANALYZERS
    • 6.3.3.1 Increasing demand for point-of-care testing to drive demand
  • TABLE 119 MAJOR PLAYERS OFFERING GAS ANALYZERS IN MARKET
  • TABLE 120 GAS ANALYZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 121 GAS ANALYZERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
• 6.4 DIAGNOSTIC RESPIRATORY CARE DEVICES
  • TABLE 122 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 123 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4.1 SPIROMETERS
    • 6.4.1.1 Rising technological advancements in spirometers to support market growth
  • TABLE 124 MAJOR PLAYERS OFFERING SPIROMETERS IN MARKET
  • TABLE 125 SPIROMETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 126 SPIROMETERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES)
    • 6.4.2.1 Rising incidence of obstructive sleep apnea to drive demand
  • TABLE 127 MAJOR PLAYERS OFFERING POLYSOMNOGRAPHY DEVICES IN MARKET
  • TABLE 128 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 129 POLYSOMNOGRAPHY DEVICES MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.4.3 PEAK FLOW METERS
    • 6.4.3.1 Low-cost and uncomplicated nature to drive segmental growth
  • TABLE 130 MAJOR PLAYERS OFFERING PEAK FLOW METERS IN MARKET
  • TABLE 131 PEAK FLOW METERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 132 PEAK FLOW METERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.4.4 OTHER DIAGNOSTIC DEVICES
  • TABLE 133 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.5 CONSUMABLES & ACCESSORIES
  • TABLE 134 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 135 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.5.1 MASKS
  • TABLE 136 MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 137 MASKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.5.1.1 Reusable masks
      • 6.5.1.1.1 Growing concerns related to air pollution to grow demand
  • TABLE 138 REUSABLE MASKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.5.1.2 Disposable masks
      • 6.5.1.2.1 Stringent government mandates on wearing masks to spur demand
  • TABLE 139 DISPOSABLE MASKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.5.2 DISPOSABLE RESUSCITATORS
    • 6.5.2.1 Growing focus on reducing cross-contamination cases in patients to foster segmental growth
  • TABLE 140 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.5.3 TRACHEOSTOMY TUBES
    • 6.5.3.1 Introduction of new and advanced products with ergonomic designs to drive market growth
  • TABLE 141 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.5.4 BREATHING CIRCUITS
    • 6.5.4.1 Healthcare professionals' efforts to improve infection control practices to grow demand
  • TABLE 142 BREATHING CIRCUITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.5.5 NASAL CANNULAE
    • 6.5.5.1 Increasing focus on minimally invasive surgery techniques to fuel demand
  • TABLE 143 NASAL CANNULAE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.5.6 OTHER CONSUMABLES & ACCESSORIES
  • TABLE 144 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION

• 7.1 INTRODUCTION
  • TABLE 145 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
• 7.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
  • 7.2.1 RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET
  • TABLE 146 RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.3 SLEEP APNEA
  • 7.3.1 GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH
  • TABLE 147 COUNTRY-WISE DATA ON SLEEP APNEA PATIENTS
  • TABLE 148 RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.4 ASTHMA
  • 7.4.1 INCREASING INCIDENCE OF COPD TO DRIVE MARKET
  • TABLE 149 RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.5 INFECTIOUS DISEASES
  • 7.5.1 GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH
  • TABLE 150 INCIDENCE OF TB (RATE PER 100,000 POPULATION)
  • TABLE 151 RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.6 OTHER DISEASE INDICATIONS
  • TABLE 152 RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

8 RESPIRATORY CARE DEVICES MARKET, BY END USER

• 8.1 INTRODUCTION
  • TABLE 153 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 8.2 HOSPITALS
  • 8.2.1 GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO DRIVE MARKET
  • TABLE 154 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.3 HOME CARE SETTINGS
  • 8.3.1 INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS TO BOOST GROWTH
  • TABLE 155 RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.4 AMBULATORY CARE CENTERS (ACCS)
  • 8.4.1 IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS TO DRIVE MARKET
  • TABLE 156 RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.5 OTHER END USERS
  • TABLE 157 RESPIRATORY CARE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

9 RESPIRATORY CARE DEVICES MARKET, BY REGION

• 9.1 INTRODUCTION
  • FIGURE 36 RESPIRATORY CARE DEVICES MARKET: REGIONAL GROWTH OPPORTUNITIES
  • TABLE 158 RESPIRATORY CARE DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 9.2 NORTH AMERICA
  • FIGURE 37 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
  • TABLE 159 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 160 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 161 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 162 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 163 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 164 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 165 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 166 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 167 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 168 NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 169 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 170 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 171 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 172 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 173 NORTH AMERICA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 174 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 175 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2.1 NORTH AMERICA: RECESSION IMPACT
  • 9.2.2 US
    • 9.2.2.1 Rapid growth in geriatric population to boost market
  • TABLE 176 US: KEY MACROINDICATORS
  • TABLE 177 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 178 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 179 US: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 180 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 181 US: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 182 US: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 183 US: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 184 US: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 185 US: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 186 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 187 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 188 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 189 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 190 US: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 191 US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 192 US: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2.3 CANADA
    • 9.2.3.1 Large pool of undiagnosed patients to drive market
  • TABLE 193 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)
  • TABLE 194 CANADA: KEY MACROINDICATORS
  • TABLE 195 CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 196 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 197 CANADA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 198 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 199 CANADA: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 200 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 201 CANADA: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 202 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 203 CANADA: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 204 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 205 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 206 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 207 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 208 CANADA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 209 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 210 CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.3 EUROPE
  • TABLE 211 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 212 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 213 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 214 EUROPE: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 215 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 216 EUROPE: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 217 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 218 EUROPE: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 219 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 220 EUROPE: NEBULIZER MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 221 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 222 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 223 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 224 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 225 EUROPE: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 226 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 227 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.1 EUROPE: RECESSION IMPACT
  • 9.3.2 GERMANY
    • 9.3.2.1 Increasing public healthcare expenditure to foster market growth
  • TABLE 228 GERMANY: KEY MACROINDICATORS
  • TABLE 229 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 230 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 231 GERMANY: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 232 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 233 GERMANY: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 234 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 235 GERMANY: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 236 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 237 GERMANY: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 238 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 239 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 240 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 241 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 242 GERMANY: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 243 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 244 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)

• 9.3.3 FRANCE
  • 9.3.3.1 High prevalence of COPD to surge demand
• TABLE 245 FRANCE: KEY MACROINDICATORS
• TABLE 246 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• TABLE 247 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 248 FRANCE: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 249 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 250 FRANCE: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 251 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 252 FRANCE: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 253 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 254 FRANCE: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 255 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 256 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• TABLE 257 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 258 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 259 FRANCE: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 260 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
• TABLE 261 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.3.4 UK
  • 9.3.4.1 Growing demand for minimally invasive surgeries to drive market
• TABLE 262 UK: KEY MACROINDICATORS
• TABLE 263 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• TABLE 264 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 265 UK: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 266 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 267 UK: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 268 UK: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 269 UK: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 270 UK: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 271 UK: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 272 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 273 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• TABLE 274 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 275 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 276 UK: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 277 UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
• TABLE 278 UK: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.3.5 ITALY
  • 9.3.5.1 Growing involvement of private sector in healthcare market to drive market
• TABLE 279 ITALY: KEY MACROINDICATORS
• TABLE 280 ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• TABLE 281 ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 282 ITALY: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 283 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 284 ITALY: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 285 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 286 ITALY: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 287 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 288 ITALY: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 289 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 290 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• TABLE 291 ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 292 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 293 ITALY: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 294 ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
• TABLE 295 ITALY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.3.6 SPAIN
  • 9.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand
• TABLE 296 SPAIN: KEY MACROINDICATORS
• TABLE 297 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• TABLE 298 SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 299 SPAIN: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 300 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 301 SPAIN: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 302 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 303 SPAIN: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 304 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 305 SPAIN: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 306 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 307 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• TABLE 308 SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 309 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 310 SPAIN: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 311 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
• TABLE 312 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.3.7 REST OF EUROPE
• TABLE 313 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• TABLE 314 REST OF EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 315 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 316 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 317 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 318 REST OF EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 319 REST OF EUROPE: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 320 REST OF EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 321 REST OF EUROPE: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 322 REST OF EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 323 REST OF EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• TABLE 324 REST OF EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 325 REST OF EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 326 REST OF EUROPE: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• TABLE 327 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
• TABLE 328 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.4 ASIA PACIFIC
  • FIGURE 38 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
  • TABLE 329 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 330 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 331 ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 332 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 333 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 334 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 335 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 336 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 337 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 338 ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 340 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 341 ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 342 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 343 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 344 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 345 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
  • 9.4.2 JAPAN
    • 9.4.2.1 Availability of universal healthcare reimbursement policy to drive market
  • TABLE 346 JAPAN: KEY MACROINDICATORS
  • TABLE 347 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 348 JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 349 JAPAN: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 350 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 351 JAPAN: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 352 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 353 JAPAN: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 354 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 355 JAPAN: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 356 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 357 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 358 JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 359 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 360 JAPAN: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 361 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 362 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.3 CHINA
    • 9.4.3.1 Initiatives to modernize healthcare system and reimbursement facilities to support market growth
  • TABLE 363 CHINA: KEY MACROINDICATORS
  • TABLE 364 CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 365 CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 366 CHINA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 367 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 368 CHINA: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 369 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 370 CHINA: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 371 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 372 CHINA: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 373 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 374 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 375 CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 376 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 377 CHINA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 378 CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 379 CHINA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.4 INDIA
    • 9.4.4.1 Increasing focus of global players on domestic market to drive market
  • TABLE 380 INDIA: KEY MACROINDICATORS
  • TABLE 381 INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 382 INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 383 INDIA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 384 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 385 INDIA: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 386 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 387 INDIA: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 388 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 389 INDIA: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 390 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 391 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 392 INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 393 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 394 INDIA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 395 INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 396 INDIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 High prevalence of chronic lung diseases to drive demand
  • TABLE 397 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 398 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 399 AUSTRALIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 400 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 401 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 402 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 403 AUSTRALIA: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 404 AUSTRALIA: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 405 AUSTRALIA: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 406 AUSTRALIA: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 407 AUSTRALIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 408 AUSTRALIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 409 AUSTRALIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 410 AUSTRALIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 411 AUSTRALIA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 412 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 413 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Expanding geriatric population to fuel market
  • TABLE 414 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 415 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 416 SOUTH KOREA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 417 SOUTH KOREA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 418 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 419 SOUTH KOREA: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 420 SOUTH KOREA: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 421 SOUTH KOREA: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 422 SOUTH KOREA: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 423 SOUTH KOREA: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 424 SOUTH KOREA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 425 SOUTH KOREA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 426 SOUTH KOREA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 427 SOUTH KOREA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 428 SOUTH KOREA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 429 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 430 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.7 REST OF ASIA PACIFIC
  • TABLE 431 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 432 REST OF ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 433 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 434 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 435 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 436 REST OF ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 437 REST OF ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 438 REST OF ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 439 REST OF ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 440 REST OF ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 441 REST OF ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 442 REST OF ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 443 REST OF ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 444 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 445 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 446 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.5 LATIN AMERICA
  • TABLE 447 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 448 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 449 LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 450 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 451 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 452 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 453 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 454 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 455 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 456 LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 457 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 458 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 459 LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 460 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 461 LATIN AMERICA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 462 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 463 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5.1 LATIN AMERICA: RECESSION IMPACT
  • 9.5.2 BRAZIL
    • 9.5.2.1 Government initiatives to improve healthcare sector to drive market
  • TABLE 464 BRAZIL: KEY MACROINDICATORS
  • TABLE 465 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 466 BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 467 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 468 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 469 BRAZIL: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 470 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 471 BRAZIL: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 472 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 473 BRAZIL: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 474 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 475 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 476 BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 477 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 478 BRAZIL: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 479 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 480 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5.3 MEXICO
    • 9.5.3.1 Rising obesity rate to increase incidence of respiratory diseases
  • TABLE 481 MEXICO: KEY MACROINDICATORS
  • TABLE 482 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 483 MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 484 MEXICO: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 485 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 486 MEXICO: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 487 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 488 MEXICO: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 489 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 490 MEXICO: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 491 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 492 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 493 MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 494 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 495 MEXICO: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 496 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 497 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5.4 REST OF LATIN AMERICA
  • TABLE 498 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 499 REST OF LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 500 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 501 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 502 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 503 REST OF LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 504 REST OF LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 505 REST OF LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 506 REST OF LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 507 REST OF LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 508 REST OF LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 509 REST OF LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 510 REST OF LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 511 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 512 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 513 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS
  • TABLE 514 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 515 MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 516 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 517 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 518 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 519 MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 520 MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 521 MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 522 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 523 MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 524 MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 525 MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 526 MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 527 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 528 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021-2028 (USD MILLION)
  • TABLE 529 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 RIGHT TO WIN/KEY STRATEGIES
• 10.3 STRATEGIES ADOPTED BY KEY PLAYERS
• 10.4 REVENUE ANALYSIS FOR TOP FIVE MARKET PLAYERS
  • FIGURE 39 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN RESPIRATORY CARE DEVICES MARKET
• 10.5 MARKET SHARE ANALYSIS
  • FIGURE 40 RESPIRATORY CARE DEVICES MARKET SHARE, BY KEY PLAYER (2022)
  • FIGURE 41 SHARE OF LEADING COMPANIES IN GLOBAL THERAPEUTIC RESPIRATORY CARE DEVICES MARKET (2022)
  • FIGURE 42 SHARE OF LEADING COMPANIES IN GLOBAL MONITORING DEVICES MARKET (2022)
  • FIGURE 43 SHARE OF LEADING COMPANIES IN GLOBAL DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET (2022)
• 10.6 COMPANY EVALUATION MATRIX
  • 10.6.1 STARS
  • 10.6.2 EMERGING LEADERS
  • 10.6.3 PERVASIVE PLAYERS
  • 10.6.4 PARTICIPANTS
  • FIGURE 44 RESPIRATORY CARE DEVICES MARKET: COMPETITIVE LEADERSHIP MATRIX, 2022
• 10.7 COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022)
  • 10.7.1 PROGRESSIVE COMPANIES
  • 10.7.2 DYNAMIC COMPANIES
  • 10.7.3 STARTING BLOCKS
  • 10.7.4 RESPONSIVE COMPANIES
  • FIGURE 45 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS, 2022
• 10.8 COMPETITIVE BENCHMARKING
  • TABLE 530 RESPIRATORY CARE DEVICES MARKET: KEY STARTUPS/SMES
  • 10.8.1 COMPANY FOOTPRINT
  • TABLE 531 FOOTPRINT OF COMPANIES, BY OFFERING (25 COMPANIES)
  • TABLE 532 FOOTPRINT OF COMPANIES, BY DISEASE INDICATION (25 COMPANIES)
  • TABLE 533 FOOTPRINT OF COMPANIES, BY END USER (25 COMPANIES)
  • FIGURE 46 OVERALL FOOTPRINT OF COMPANIES (25 COMPANIES)
  • 10.8.2 COMPETITIVE SCENARIOS AND TRENDS
  • 10.8.3 PRODUCT LAUNCHES
  • TABLE 534 RESPIRATORY CARE DEVICES MARKET: PRODUCT LAUNCHES (2019-2023)
  • 10.8.4 DEALS
  • TABLE 535 RESPIRATORY CARE DEVICES MARKET: DEALS (2019-2023)

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
• (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
• 11.1.1 KONINKLIJKE PHILIPS N.V.
• TABLE 536 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
• FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
• 11.1.2 MEDTRONIC
• TABLE 537 MEDTRONIC: BUSINESS OVERVIEW
• FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2022)
• 11.1.3 RESMED
• TABLE 538 RESMED: BUSINESS OVERVIEW
• FIGURE 49 RESMED: COMPANY SNAPSHOT (2022)
• 11.1.4 MASIMO
• TABLE 539 MASIMO: BUSINESS OVERVIEW
• FIGURE 50 MASIMO: COMPANY SNAPSHOT (2022)
• 11.1.5 FISHER & PAYKEL HEALTHCARE LIMITED
• TABLE 540 FISHER & PAYKEL HEALTHCARE LIMITED: BUSINESS OVERVIEW
• FIGURE 51 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2022)
• 11.1.6 DRAGERWERK AG & CO. KGAA
• TABLE 541 DRAGERWERK AG & CO. KGAA: BUSINESS OVERVIEW
• FIGURE 52 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022)
• 11.1.7 GETINGE
• TABLE 542 GETINGE: BUSINESS OVERVIEW
• FIGURE 53 GETINGE: COMPANY SNAPSHOT (2022)
• 11.1.8 NIHON KOHDEN CORPORATION
• TABLE 543 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
• FIGURE 54 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
• 11.1.9 GE HEALTHCARE
• TABLE 544 GE HEALTHCARE: BUSINESS OVERVIEW
• FIGURE 55 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
• 11.1.10 VYAIRE MEDICAL, INC.
• TABLE 545 VYAIRE MEDICAL, INC.: BUSINESS OVERVIEW
• 11.1.11 BAXTER INTERNATIONAL, INC.
• TABLE 546 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
• FIGURE 56 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)
• 11.1.12 ADAPTHEALTH, LLC
• TABLE 547 ADAPTHEALTH, LLC: BUSINESS OVERVIEW
• FIGURE 57 ADAPTHEALTH, LLC: COMPANY SNAPSHOT (2022)
• 11.1.13 ROTECH HEALTHCARE, INC.
• TABLE 548 ROTECH HEALTHCARE INC.: BUSINESS OVERVIEW
• 11.1.14 TELEFLEX INCORPORATED
• TABLE 549 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
• FIGURE 58 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
• 11.1.15 AIR LIQUIDE
• TABLE 550 AIR LIQUIDE: BUSINESS OVERVIEW
• FIGURE 59 AIR LIQUIDE: COMPANY SNAPSHOT (2022)
• 11.2 OTHER PLAYERS
  • 11.2.1 INVACARE CORPORATION
  • TABLE 551 INVACARE CORPORATION: BUSINESS OVERVIEW
  • FIGURE 60 INVACARE CORPORATION: COMPANY SNAPSHOT (2022)
  • 11.2.2 ICU MEDICAL
  • TABLE 552 ICU MEDICAL: BUSINESS OVERVIEW
  • FIGURE 61 ICU MEDICAL: COMPANY SNAPSHOT (2022)
  • 11.2.3 HAMILTON MEDICAL AG
  • TABLE 553 HAMILTON MEDICAL AG: BUSINESS OVERVIEW
  • 11.2.4 APEX MEDICAL CORP
  • TABLE 554 APEX MEDICAL CORP: BUSINESS OVERVIEW
  • 11.2.5 MEDLINE INDUSTRIES, LP
  • TABLE 555 MEDLINE INDUSTRIES, LP: BUSINESS OVERVIEW
  • 11.2.6 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH
  • TABLE 556 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH: BUSINESS OVERVIEW
  • 11.2.7 NONIN
  • 11.2.8 ALLIED MEDICAL LLC
  • 11.2.9 DRIVE DEVILBISS HEALTHCARE
  • 11.2.10 OMRON HEALTHCARE, INC.
• *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

관련자료